Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 242 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA260476
AI69309
Grant: AI69309
NCI NIH HHS
Grant: U01 CA260476
NIAID NIH HHS
Grant: R21 AI169309
NIAID NIH HHS
Grant: R37 AI150590
National Institutes of Health
Grant: 5R03CA069309-03
ARYL SULFOTRANSFERASE EFFECT ON CISPLATIN MUTAGENICITY
National Institutes of Health
Grant: 3U01CA260476-02S2
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
Musk Foundation
Massachusetts Consortium on Pathogen Readiness
Ragon Institute of MGH, MIT and Harvard
FWCI
40.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 1 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 2 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 2 of Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Additional file 2 of Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Additional file 2 of Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Additional file 1 of Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Additional file 1 of Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern